Skip to main content

Animations

MJFF Publications

4931 - 4940 of 8587 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2025
  • 2022
  • 2022
  • 2024
  • 2015
  • 2020
  • 2021
  • 2018
  • Summary Details
    OPEN
    Title: Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcae163
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cholinergic system correlates of postural control changes in Parkinson’s disease freezers
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad134
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf204
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.1529
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s22186831
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Fast, multicolour optical sectioning over extended fields of view with patterned illumination and machine learning
    Journal Name: Biomedical Optics Express
    Publisher: Optica Publishing Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1364/boe.510912
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Deep clinical and neuropathological phenotyping of Pick disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24559
    Citation Count: 170
  • Summary Details
    OPEN
    Title: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2111643118
    Citation Count: 63
  • Summary Details
    RESTRICTED
    Title: Mendel and urate: Acid test or random noise?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.005
    Best OA location URL:
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.